Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.
HIV/AIDS continues to disproportionately affect Black Americans, despite overall progress in reducing infection rates.
MASAKA, Uganda—Every morning for the past four years, Agnes Mutesi, 30, has taken a pill that prevents her from getting ...
Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results